4//SEC Filing
SEELEY BRUCE J. 4
Accession 0000899243-22-010769
CIK 0000891293other
Filed
Mar 10, 7:00 PM ET
Accepted
Mar 11, 7:40 PM ET
Size
8.7 KB
Accession
0000899243-22-010769
Insider Transaction Report
Form 4
SEELEY BRUCE J.
EVP, Chief Commercial Officer
Transactions
- Award
Common Stock
2021-06-30$2.13/sh+3,164$6,724→ 40,664 total - Award
Common Stock
2021-12-31$2.11/sh+3,241$6,832→ 43,905 total - Award
Stock Option (right to buy)
2022-03-09+280,000→ 280,000 totalExercise: $4.49Exp: 2032-03-09→ Common Stock (280,000 underlying)
Footnotes (2)
- [F1]Shares acquired under the CTI BioPharma Corp. 2007 Employee Stock Purchase Plan.
- [F2]The stock option will vest in six equal semi-annual installments over a three-year period, subject to continued employment with the Company through the applicable vesting dates.
Documents
Issuer
CTI BIOPHARMA CORP
CIK 0000891293
Entity typeother
Related Parties
1- filerCIK 0001474462
Filing Metadata
- Form type
- 4
- Filed
- Mar 10, 7:00 PM ET
- Accepted
- Mar 11, 7:40 PM ET
- Size
- 8.7 KB